Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia

被引:29
|
作者
Phung Anh Nguyen [1 ]
Islam, Mohaimenul [1 ,2 ]
Galvin, Cooper J. [1 ]
Chang, Chih-Cheng [3 ,4 ]
An, Soo Yeon [5 ]
Yang, Hsuan-Chia [4 ]
Huang, Chih-Wei [1 ]
Li, Yu-Chuan [1 ,4 ,6 ]
Iqbal, Usman [1 ,7 ]
机构
[1] Taipei Med Univ, Coll Med Sci & Technol, Int Ctr Hlth Informat Technol, Taipei 11031, Taiwan
[2] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei 11031, Taiwan
[3] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, New Taipei 235, Taiwan
[4] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei 11031, Taiwan
[5] Chungnam Natl Univ Hosp, Dept Cardiol, Daejeon 35015, South Korea
[6] Wan Fang Hosp, Dept Dermatol, Taipei 116, Taiwan
[7] Taipei Med Univ, Coll Publ Hlth, Global Hlth & Dev Dept, Global Hlth & Hlth Secur, Taipei 11031, Taiwan
关键词
clinical study; epidemiology; gastrointestinal diseases; pneumonia; proton pump inhibitors; OBSTRUCTIVE PULMONARY-DISEASE; STRESS-ULCER; ADULTS; HOSPITALIZATION; PREVENTION; MANAGEMENT; DIAGNOSIS; THERAPY;
D O I
10.1093/intqhc/mzaa041
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: Proton pump inhibitors (PPIs), one of the most widely used medications, are commonly used to suppress several acid-related upper gastrointestinal disorders. Acid-suppressing medication use could be associated with increased risk of community-acquired pneumonia (CAP), although the results of clinical studies have been conflicting. Data sources: A comprehensive search of MEDLINE, EMBASE and Cochrane library and Database of Systematic Reviews from the earliest available online year of indexing up to October 2018. Study selection: We performed a systematic review and meta-analysis of observational studies to evaluate the risk of PPI use on CAP outcomes. Data extraction: Included study location, design, population, the prevalence of CAP, comparison group and other confounders. We calculated pooled odds ratio (OR) using a random-effects meta-analysis. Results of data synthesis: Of the 2577 studies screening, 11 papers were included in the systematic review and 7 studies with 65 590 CAP cases were included in the random-effects meta-analysis. In current PPI users, pooled OR for CAP was 1.86 (95% confidence interval (CI), 1.30-2.66), and in the case of recent users, OR for CAP was 1.66 (95% CI, 1.22-2.25). In the subgroup analysis of CAP, significance association is also observed in both high-dose and low-dose PPI therapy. When stratified by duration of exposure, 3-6 months PPIs users group was associated with increased risk of developing CAP (OR, 2.05; 95% CI, 1.22-3.45). There was a statistically significant association between the PPI users and the rate of hospitalization (OR, 2.59; 95% CI, 1.83-3.66). Conclusion: We found possible evidence linking PPI use to an increased risk of CAP. More randomized controlled studies are warranted to clarify an understanding of the association between PPI use and risk of CAP because observational studies cannot clarify whether the observed epidemiologic association is a causal effect or a result of unmeasured/residual confounding.
引用
收藏
页码:292 / 299
页数:8
相关论文
共 50 条
  • [21] CORTICOSTEROIDS IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS: A META-ANALYSIS
    Nie, W.
    RESPIROLOGY, 2011, 16 : 54 - 55
  • [22] Prognosis and outcomes of patients with community-acquired pneumonia - A meta-analysis
    Fine, MJ
    Smith, MA
    Carson, CA
    Mutha, SS
    Sankey, SS
    Weissfeld, LA
    Kapoor, WN
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02): : 134 - 141
  • [23] Corticosteroid Therapy for Severe Community-Acquired Pneumonia: A Meta-Analysis
    Cheng, Ming
    Pan, Zhi-yong
    Yang, Jiong
    Gao, Ya-dong
    RESPIRATORY CARE, 2014, 59 (04) : 557 - 563
  • [24] Prevalence and risk factors for bacteremia in community-acquired pneumonia: A systematic review and meta-analysis
    Wu, Shanshan
    Chen, Lin
    Zhang, Xiaoyan
    Fan, Jiali
    Tang, Fajuan
    Xiao, Dongqiong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 151
  • [25] Corticosteroid in non-COVID-19 induced community-acquired pneumonia, a meta-analysis
    Liu, Jian
    Dong, Yongquan
    Chen, Jia
    Jin, Yuqing
    Qiu, Yunqing
    Huang, Lingtong
    HEART & LUNG, 2024, 65 : 59 - 71
  • [26] THE USE OF DISTRIBUTED-PROTOCOL PROSPECTIVE META-ANALYSIS OF OBSERVATIONAL STUDIES TO ASSESS ADVERSE DRUG EFFECTS: PROTON-PUMP INHIBITORS AND THE RISK OF HOSPITALIZATION FOR COMMUNITY-ACQUIRED PNEUMONIA.
    Filion, K. B.
    Chateau, D.
    Dormuth, C. R.
    Gershon, A.
    Targownik, L. E.
    Durand, M.
    Tamim, H.
    Teare, G. F.
    Ravani, P.
    Ernst, P.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S142 - S142
  • [27] Use of proton pump inhibitors and the risk of community-acquired pneumonia - A population-based case-control study
    Gulmez, Sinem Ezgi
    Holm, Anette
    Frederiksen, Henrik
    Jensen, Thoger Gorm
    Pedersen, Court
    Hallas, Jesper
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (09) : 950 - 955
  • [29] THE USE OF DISTRIBUTED-PROTOCOL PROSPECTIVE META-ANALYSIS OF OBSERVATIONAL STUDIES TO ASSESS ADVERSE DRUG EFFECTS: PROTON-PUMP INHIBITORS AND THE RISK OF HOSPITALIZATION FOR COMMUNITY-ACQUIRED PNEUMONIA.
    Filion, K. B.
    Chateau, D.
    Dormuth, C. R.
    Gershon, A.
    Targownik, L. E.
    Durand, M.
    Tamim, H.
    Teare, G. F.
    Ravani, P.
    Ernst, P.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S144 - S144
  • [30] Viral infection in community-acquired pneumonia: a systematic review and meta-analysis
    Burk, Michael
    El-Kersh, Karim
    Saad, Mohamed
    Wiemken, Timothy
    Ramirez, Julio
    Cavallazzi, Rodrigo
    EUROPEAN RESPIRATORY REVIEW, 2016, 25 (140): : 178 - 188